Radiation during surgery for malignant brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a type of radiation therapy given directly during brain surgery to remove a malignant tumor. The goal is to see if it is safe and effective in treating the tumor right at the time of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old, and not pregnant or breastfeeding.
- You need to be in reasonably good general health, able to do most daily activities (KPS 60 or higher).
- Your tumor is a high-grade glioma or another type of malignant brain tumor, confirmed by MRI and CT scans.
- You must not have had any prior radiation or chemotherapy for this brain tumor.
- The tumor must be located where surgeons can safely remove most of it (more than 90%).
- You must be able to have surgery and radiation therapy without any medical conditions that would make these unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This trial tests a special form of radiation therapy for older or frail adults with a type of brain tumor called glioma. The radiation is placed directly in the area where the tumor was removed during surgery, which may help prevent the tumor from growing back.
This trial tests giving a precise dose of radiation directly to the tumor area during surgery for newly diagnosed glioblastoma. The goal is to destroy remaining tumor cells immediately after removal, which may improve outcomes.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.